z-logo
open-access-imgOpen Access
Selective serotonin reuptake inhibitor use is associated with worse sleep-related breathing disturbances in individuals with depressive disorders and sleep complaints: a retrospective study
Author(s) -
Rébecca Robillard,
Mysa Saad,
L. Bryan Ray,
Brad Bujaki,
Alan B. Douglass,
Elliott K. Lee,
Louis Soucy,
Naomi Spitale,
Joseph De Koninck,
Tetyana Kendzerska
Publication year - 2020
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.8942
Subject(s) - non rapid eye movement sleep , serotonin reuptake inhibitor , polysomnography , medicine , anesthesia , antidepressant , reuptake inhibitor , major depressive disorder , sleep disorder , psychology , psychiatry , insomnia , apnea , electroencephalography , amygdala , hippocampus
The effects of serotonergic agents on respiration neuromodulation may vary according to differences in the serotonin system, such as those linked to depression. This study investigated how sleep-related respiratory disturbances relate to depression and the use of medications commonly prescribed for depression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom